Phafag AG
🇱🇮Liechtenstein
Clinical Trials
2
Active:1
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Caroverin and Inner Ear Diseases
Phase 3
Suspended
- Conditions
- Tinnitus
- Interventions
- Drug: Caroverin
- First Posted Date
- 2010-08-04
- Last Posted Date
- 2015-08-07
- Lead Sponsor
- Phafag AG
- Target Recruit Count
- 170
- Registration Number
- NCT01174979
- Locations
- 🇦🇹
Landeskrankenhaus Feldkirch, Feldkirch, Vorarlberg, Austria
News
No news found